These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4408089)

  • 1. [Pharmacokinetics and metabolite spectrum of glisoxepide in humans].
    Speck U; Mützel W; Kolb KH; Acksteiner B; Schulze PE
    Arzneimittelforschung; 1974 Mar; 24(0):404-9. PubMed ID: 4408089
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of radioactively labeled glisoxepide in the animal].
    Kolb KH; Schulze PE; Speck U; Acksteiner B
    Arzneimittelforschung; 1974 Mar; 24(0):397-403. PubMed ID: 4211553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protein binding of glisoxepide and its influence on the protein binding of phenprocoumon].
    Schlossmann K
    Arzneimittelforschung; 1974 Mar; 24(0):392-7. PubMed ID: 4408096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics of glibornuride].
    Rentsch G; Schmidt HA; Rieder J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2209. PubMed ID: 4679250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes].
    Blumenbach L; Kiesselbach NH; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):437-46. PubMed ID: 4603692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of a new antidiabetic agent in patients with limited kidney function].
    Rentsch G; Forgó I; Dubach UC
    Schweiz Med Wochenschr; 1972 May; 102(18):650-3. PubMed ID: 5033179
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of a new hypoglycemic agent SPC-703.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(2):165-72. PubMed ID: 7454622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 1. Establishment of proof and methods].
    Lehnert J; Kiesselbach NH; Blumenbach L
    Arzneimittelforschung; 1974 Mar; 24(0):433-7. PubMed ID: 4603693
    [No Abstract]   [Full Text] [Related]  

  • 12. [Human pharmacokinetics and metabolism of 14C-labeled gliquidone (AR-DF 26)].
    Kopitar Z
    Arzneimittelforschung; 1975 Sep; 25(9):1455-60. PubMed ID: 1103897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isotope technics in studies on dilazep pharmacokinetics and metabolism in man].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1972 Oct; 22(10):1651-5. PubMed ID: 4677052
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and biotransformation of chlorpropamide in the rat and dog.
    Taylor JA
    Drug Metab Dispos; 1974; 2(3):221-7. PubMed ID: 4152995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Isotope technics in studies on dilazep pharmacokinetics and metabolism in the rat].
    Schaumlöffel E; Clausnitzer M
    Arzneimittelforschung; 1972 Oct; 22(10):1643-50. PubMed ID: 4677051
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
    Pettipierre B; Fabre J
    Schweiz Med Wochenschr; 1972 Apr; 102(16):570-8. PubMed ID: 5019376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in oral antidiabetic therapy].
    Rambert P
    Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
    Balant L; Zahnd G; Gorgia A; Schwarz R; Fabre J
    Diabetologia; 1973 Sep; ():331-8. PubMed ID: 4772979
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
    Kiesselbach NH; Blumenbach L; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):447-52. PubMed ID: 4603694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of deficient kidney function on behavior of glipizide (hypoglycemic sulfonylurea) and its metabolites].
    Fabre J; Balant L; Zahnd G
    J Urol Nephrol (Paris); 1973; 79(4):380-1. PubMed ID: 4720133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.